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A B S T R A C T We studied the effect of furosemide on pulmonary transvascular filtration of fluid and microvascular permeability to plasma proteins by measuring steady-state lung lymph flow and protein flow, pulmonary arterial and left atrial pressures in nine 1-wk-old unanesthetized lambs before and after rapid intravenous infusion offurosemide, 1 mg/kg in 10 experiments and 8 mg/kg in 5 experiments. With rapid diuresis induced by furosemide (an eightfold increase in urine flow), lung vascular pressures decreased, protein concentrations of lymph and plasma increased, and there was a consistent decrease in lymph flow and lymph protein flow, more pronounced after the larger dose. Five additional lambs received 8 mg/kg of furosemide intravenously in the presence of saline-induced pulmiionary edema; in these experiments, the decrease in vascular pressures, increase in transvascular protein gradient, and decrease in lymph flow were greater thani in lambs without pulmonary edema. These findings suggest that furosemide decreases transvascular filtration of fluid in the lung by diminishing the transvascular hydraulic pressure gradienit and increasing the transvascular gradient for protein osmotic pressure. In five acute experiments on anesthetized lambs with kidneys removed, 8 mg/kg of intravenous furosemide decreased lymph flow one-half as much as it did in the presence of kidneys, with no change in lung vascular pressures or protein concentrations. The results of experiments in lambs without kidneys are consistent with a reduction in the vas-
INTRODUCTION
Furosemide is a potent sulfonamide diuretic which has become a mainstay in the treatment of pulmonary edema. Several investigators have attributed its benefits to reduced plasma volume and pulmonary vascular pressures that result from diuresis (1) (2) (3) (4) . Others have suggested that patients with pulmonary edema derive rapid improvement from furosemide even before diuresis, because of an extrarenal site of action (5-7), possibly related to changes in pulmonary blood volume.
Measurement of the volume of extravascular lung water by the double-indicator dilution method (8) and determination of arterial blood gas tensions (9) in patients before and after the administration of furosemide have demonstrated no significant acute changes. These methods may not be sufficiently sensitive to detect rapid but small changes in the volume and distribution of lung fluid, and may demand a longer duration of diuretic therapy to distinguish significant differences. The work of Staub and associates (10) (11) (12) (13) (14) showed that measurement of steady-state pulmonary lymph flow and protein flow in sheep can be used to demonstrate small changes in lung fluid dynamics.
We studied the mechanism of action of furosemide on pulmonary transvascular filtration of fluid and microvascular permeability to plasma proteins by observing the effects of the drug on steady-state lung vascular pressures, pulmonary lymph flow, and lymph protein flow in unanesthetized 7-10-day-old lambs. Furosemide decreased pulmonary vascular pressures, increased plasma protein concentration, and induced a dose-dependent decrease of lung lymph flow, consistent with a reduction of net transvascular filtration of fluid in the lung. The effect was greatest in five lambs with pulmonary edema induced by infusions of saline. In acute experiments on five lambs with kidneys removed, lymph flow also decreased after furosemide, but to a lesser extent than in the chronic experiments, with no change in pulmonary vascular pressures or protein concentrations, thus suggesting a partial extrarenal effect on pulmonary transvascular fluid dynamics. METHODS Preparation of lambs. Our preparation for these experiments has been described in detail elsewhere (12, 15) . We surgically prepared 14 newborn lambs (average birth wt 3.8 kg, range 2.3-5.2 kg) to isolate and collect lung lymph and measure average pulmonary arterial (Ppa)l and average left atrial (Pla) pressures. Each lamb had two thoracotomies, the first within 48 h after birth and the second 4-7 days later. They received anesthesia with halothane and nitrous oxide and were ventilated with a piston-type respirator (model 607, Harvard Apparatus Co., Inc., Millis, Mass.) during surgery. Before and after surgery, and between experiments, the lambs remained with their ewes for feeding and warmth.
In the first operation, we placed polyvinyl catheters in the thoracic aorta, both atria, and the pulmonary artery. After the lambs recovered, a second thoracotomy was done to obtain pulmonary lymph. In lambs, about two-thirds of the lung lymph flows into the thoracic duct by way of the caudal mediastinal lymph node (16, 17) , which is a long, narrow structure located in the posterior mediastinum between the aorta and esophagus on the right side of the chest. We ligated and severed the systemic contributions to that lymph node and inserted a heparin-coated polyvinyl catheter, internal diameter 0.011 or 0.015 inches, into the efferent duct of that node for collection of nearly pure pulmonary lymph. Previous studies on adult sheep demonstrated that this fluid is not contaminated by lymph of systemic origin (12) . We tunneled the catheter beneath the pleura, brought it through the chest wall, secured it to the skin with a suture, and protected it with a canvas pouch. In addition, we placed a polyvinyl catheter in the pleural space for postoperative drainage of pleural fluid and air. After surgery, the lambs had at least 2 days to recover, and experiments did not begin until the pleural cavity was free of fluid and the lymph contained no visible blood and flowed at a steady rate.
Chronic experiments. The average wt of the lambs at the time of experiments was 5.9 kg (range 4.1-7.9 kg). During experiments, we kept the lambs, without restraints, in a cardboard box. We measured Ppa, Pla, and the phasic aortic blood pressure continuously with calibrated pressure transducers (Statham P23 Dc, Statham Instruments, Inc., Oxnard, Calif.) and a four-channel amplifier-recorder (Grass model 7B polygraph, 7DAE amplifiers, and 7P1B preamplifiers, Grass Instrument Co., Quincy, Mass.). Zero reference level for all pressure measurements was a line drawn at the time of surgery on the lamb's skin at the level of the left atrium.
We measured lymph flow to the nearest 0.01 ml at 30-min intervals for 2 h during a steady-state base-line period and for 4 h after rapidly injecting furosemide (Lasix, 10 mg/ml, Hoechst-Roussel Pharmaceuticals, Somerville, N. J.) into the right atrium. We collected samples of lymph and blood in heparinized test tubes every 30 min, with blood specimens taken at the midpoint of each lymph collection period. In 10 experiments performed on eight lambs, we infused 1 mg/kg of furosemide and observed the effects on pulmonary lymph I Abbreviations used in this paper: Pla, average left atrial pressure; Ppa, average pulmonary arterial pressure. flow and hemodynamics. On separate days, five of the lambs received 8 mg/kg of furosemide after a steady-state base-line period. We collected urine either by an indwelling polyvinyl catheter in the bladder or by intermittent emptying of a plastic receptacle suspended beneath the lambs. We measured heart rate, respiratory rate, and rectal temperature, and obtained samples of arterial blood for measurement of pH and blood gas tensions at frequent intervals.
Pulmonary edema experiments. We induced pulmonary edema in five lambs, more than doubling their steady-state base-line lymph flow, by infusing sterile isotonic saline solution, 154 meq/liter, intravenously at a rate of 150-200 ml/kg per h for 3 h. We measured Ppa, Pla, protein concentrations, and lymph flow for at least 2 h after the infusion, sufficiently long to permit equilibration, and then during a 2-h period after the injection into the right atrium of furosemide,
Acute experiments in lambs without kidneys. In five lambs less than 2-wk-old that weighed an average of 7.0 kg (range 5.4-10.0 kg), we did bilateral thoracotomies as previously described, in addition to bilateral nephrectomies (without adrenalectomy), and then measured steady-state lymph flow and vascular pressures under anesthesia with halothane and nitrous oxide for 2 h before and 4 h after 8 mg/kg ofintravenous furosemide. Except for the anesthesia and mechanical ventilation, the experiments were almost identical in design to the chronic studies. We killed the lambs 4 h after the infusion of furosemide. We measured vascular pressures and lymph flow for 6-8 h in two anesthetized, anephric control lambs, given no furosemide.
Post-mortem studies. At the conclusion of experiments on each animal, we injected pentobarbital sodium, 20 mg/kg, into the right atrium, placed the lamb in the supine position, ventilated the lungs with 20 ml/kg of air via the Harvard respirator (Harvard Apparatus, Co., Inc.), and rapidly split the sternum to excise both lungs. We clamped the hili ofthe lungs at end-inspiration with the heart still beating, and removed the lungs for measurement of extravascular water and dry lung tissue weight. We did this with six lambs under base line conditions (no furosemide) (15) , with six lambs 4 h after they received 1 mg/kg of furosemide, and with five anephric lambs 4 h after they received 8 mg/kg of furosemide.
Analytic methods. We centrifuged samples of lymph and blood and measured the concentration of protein in the supernates by the Biuret method (18) , and albumin and globulin fractions by cellulose-acetate electrophoresis (Microzone 110, Beckman Instruments, Inc., Fullerton, Calif.). We measured arterial blood gas tensions on a blood-gas analyzer (AcidBase Analyzer PHM 71, Radiometer Co., Copenhagen, Denmark) with calibration at 40°C, the normal body temperature of lambs.
We calculated the weight of extravascular lung water per gram of dry lung tissue, exclusive of blood, for all lambs by a modification (11, 13) of the method described by Pearce et al. (19) . We expressed pulmonary lymph flow and protein flow (lymph flow x lymph protein concentration) relative to the weight of dry bloodless lung tissue. In addition, we expressed protein flow in relation to the concentration of protein in the plasma of each animal.
Statistics. We compared average steady-state measurements made before and after infusion of furosemide for each experiment, with the paired t test for statistical analysis (20) . We accepted P < 0.05 as indicative of significant differences. Post-mortem lung water measurements made after base-line experiments and furosemide experiments were compared by the unpaired t test. All summary results in both the text and the tables are expressed as the mean+ 1 SEM. RESULTS 1-mg/kg experiments. Fig. 1 illustrates the results of a typical study in which a lamb received 1 mg/kg of furosemide after a 2-h base-line period. Associated with the ensuing diuresis, Ppa and Pla decreased, but only slightly, phasic aortic blood pressure did not change, protein concentrations and hematocrit increased, and lung lymph flow diminished. Table I lists the important data related to pulmonary transvascular fluid filtration and microvascular permeability to plasma proteins for 10 such experiments carried out on eight lambs. Ppa did not change significantly; there was a small but significant decrease in Pla, an increase in lymph (12%) and plasma (8%) protein concentrations, and a 28% decrease in lymph flow, with diminished protein flow as well. There was no consistent change in the lymph concentration of total protein relative to that in plasma after furosemide.
Urine flow increased abruptly from 3+1 ml/kg per h during the base-line period to 24+4 ml/kg per h during the 2 h after furosemide. In lambs with catheters in the bladder, we detected a substantial increase in urine flow within 5 min of the furosemide infusion, reaching a maximal flow rate between 15 The average hematocrit increased from 27+1 to 29+1. Neither the phasic aortic blood pressure (88+3/53+2 torr to 87±3/52±2 torr) nor the heart rate (189±4/min to 193±5/min) changed significantly, but respiratory frequency did decrease from 86+7/min to 69±4/min, with a significant decline in the average CO2 pressure in arterial blood from 39±2 torr to 37±1 torrand an increase in pH from 7 Urine output increased from 4±0.3 ml/kg per h to 33±4 ml/kg per h after furosemide, and average hematocrit increased from 27±0.3 to 30±1%. As with the lower dose, there was no significant change in heart rate, systolic blood pressure, or 02 pressure in arterial blood, but diastolic blood pressure in the aorta declined (by an average decrement of seven torr) in all five experiments; CO2 pressure in arterial blood decreased and pH increased in four studies.
Pulmonary edema experiments. Fig. 3 illustrates a typical experiment in which we infused isotonic saline intravenously at a rate of 165 ml/kg per h for 3 h to induce pulmonary edema, allowed 2-3 h for a "quasisteady state" to develop, and then injected furosemide, 8 mg/kg, into the right atrium. Lymph flow decreased abruptly, though Ppa and Pla remained unchanged for more than 30 min, after which they decreased. While plasma protein concentration increased soon after the injection of furosemide, lymph protein concentration did not increase for more than 1 h, thereby augmenting the transvascular gradient for protein. Table III lists data related to pulmonary hemodynamics, transvascular fluid and protein transport, and arterial blood gas tensions for the five lambs given furosemide during saline-induced pulmonary edema. In all cases, Ppa and Pla decreased, plasma protein concentration increased, and lymph flow and protein flow decreased. Associated based on studies of Gaar et al., [22] ) and protein osmotic pressures, derived from measurements of albumin and globulin concentrations applied to the curves of Landis and Pappenheimer (23) . In all five lambs, estimated pulmonary microvascular pressures decreased and the transvascular gradient for protein osmotic pressure increased. Acute experiments. Fig. 4 shows the results of an experiment in which a lamb without kidneys received 8 mg/kg of furosemide. Lymph flow decreased, with no change in vascular pressures or protein concentrations. Table V lists the results of five such studies performed on anesthetized lambs without kidneys. Despite the fact that Ppa, Pla, and protein concentrations did not change, lymph flow decreased by an average of 17% after 8 mg/kg of furosemide. This observation was consistent in all five experiments and differed from two control experiments in which we studied lambs without kidneys for up to 8 h without giving furosemide, and found no decrease in lymph flow.
Post-mortem studies. Extravascular 
DISCUSSION
Furosemide has been used to treat pulmonary edema for more than a decade, yet its action on fluid dynamics within the lung has been inaccessible without a sensitive method for detecting small changes in the net transvascular flow of fluid. The technique of Staub and his associates (10) (11) (12) (13) (14) has permitted us to examine more closely the changes in liquid movement which occur in the lung after furosemide. Our results suggest that it reduces transvascular filtration of fluid in the lung, more so after 8 mg/kg than after 1 mg/kg; the effect was most pronounced in the presence of pulmonary edema. Estimates of pulmonary microvascular pressures and protein osmotic pressures suggest that the changes in lymph flow reflect both a decrease in the pulmonary transvascular hydraulic pressure gradient and an in- crease in the transvascular gradient for protein osmotic pressure. In addition, the drug appears to have a partial effect even in the absence of kidneys, without any change in lung vascular pressures or protein concentrations. Despite the fact that lymph flow in lambs decreased after infusion of furosemide, extravascular lung water was not significantly different for lambs killed 4 h after receiving the diuretic compared to lambs killed after no diuretic. This finding confirms the observations of Brigham et al. (11) and Erdmann et al. (13) that in sheep measurement of pulmonary lymph flow is a more sensitive index of transvascular fluid filtration than measurement of extravascular lung water.
Lal et al. (1) found no significant change in Ppa or Pla after furosemide in human patients with an initial Pla less than 10 torr; when Pla was above 10 torr however, furosemide caused a significant decrease in Ppa and Pla. Decreases of Ppa and Pla were small and inconsistent in our base-line experiments, perhaps because these were normal lambs; the changes were more evident in lambs with pulmonary edema from circulatory overload. Under these circumstances, furosemide not only reduced filtration pressure in the lung, but also induced significant improvement of arterial blood gas tensions, presumably from enhanced clearance of excessive interstitial and perhaps some alveolar fluid.
While many investigators have directed their interest to effects of furosemide on pulmonary vascular pressures (1-4, 8, 24, 25 ), the influence of the drug on the transvascular protein osmotic pressure gradient has re- (28) showed that furosemide increased nonpulmonary lymph flow through the thoracic duct in dogs with or without kidneys, despite no significant change in systemic arterial or venous pressures. They concluded that furosemide produces shifts in body water by an undefined extrarenal action. Stowe and Hook (29) found that lymph flow from the kidney of anesthetized dogs is a function of renal blood flow, which increases after furosemide; that is, renal lymph flow increases with increased blood flow to the kidneys (1-4, 6, 8, 24) , even in the absence of kidneys (25) . Bourland et al. (25) recently reported that even after nephrectomy, dogs had an unexplained, significant decrease in cardiac index, with no change in pulmonary arterial or pulmonary arterial wedge pressures. If this were also true in lambs, then furosemide could decrease pulmonary lymph flow by decreasing blood flow to the lungs, thereby reducing filtration pressure; or in the absence of kidneys, where there is no change in vascular pressures, it might reduce pulmonary blood volume and limit the vascular surface area for exchange of fluid and solute, thereby decreasing lymph flow. This hypothesis is consistent with our findings in anephric lambs.
Alternatively, furosemide could lessen microvascular permeability to protein, a possibility which we cannot exclude with our results. However, the fact that the concentration of albumin relative to globulin in lymph did not increase after furosemide makes this possibility unlikely, as decreased permeability implies a change in the sieving properties of the microvascular membrane, such that we would expect greater restriction of proteins of large molecular weight. It is possible, nevertheless, that our protein fractionation dry bloodless lung tissue and plasma protein concentration. method is not sufficiently sensitive to detect such changes.
Is it possible that furosemide inhibits lymphatic motility 4nd thereby reduces pulmonary lymph flow in the absence of diuresis? The fact that lung water content did not increase with the decrease in lymph flow caused by furosemide is strong evidence that the drug does not inhibit lymph propulsion, but that it merely reduces transvascular fluid filtration. The finding of increased lymph flow through renal hilar channels (29) and the thoracic duct (28) after furosemide is further evidence that the drug is not a lymphatic depressant.
From our observations of lambs with kidneys, we conclude that a major action of furosemide is its diuretic effect, which decreases lung vascular hydraulic pressure, increases the transvascular gradient for protein osmotic pressure, and thereby diminishes the net transvascular filtration of fluid in the lung. Our results suggest that this effect is dose-related and most evident during pulmonary edema.
